{"entities":{"Q133803":{"pageid":135334,"ns":120,"title":"Item:Q133803","lastrevid":59824080,"modified":"2026-04-10T14:05:12Z","type":"item","id":"Q133803","labels":{"en":{"language":"en","value":"Bayesian optimal interval designs for phase I clinical trials"}},"descriptions":{"en":{"language":"en","value":"scientific article"}},"aliases":{},"claims":{"P31":[{"mainsnak":{"snaktype":"value","property":"P31","hash":"fd5912e4dab4b881a8eb0eb27e7893fef55176ad","datavalue":{"value":{"entity-type":"item","numeric-id":56887,"id":"Q56887"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q133803$90F76A49-22BC-4303-AF98-FD8745BC2B75","rank":"normal"}],"P200":[{"mainsnak":{"snaktype":"value","property":"P200","hash":"e44935e2431628ddb988bbfab68474fede5136f0","datavalue":{"value":{"entity-type":"item","numeric-id":133800,"id":"Q133800"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q133803$26517880-0E77-48DD-A3B5-1B97D959330D","rank":"normal"}],"P26":[{"mainsnak":{"snaktype":"value","property":"P26","hash":"2ee2ffff950782f05247d4c7f47b65094b98d4f9","datavalue":{"value":"64","type":"string"},"datatype":"string"},"type":"statement","id":"Q133803$61886D2D-B7C9-4F45-9C67-8849ED2088BA","rank":"normal"}],"P25":[{"mainsnak":{"snaktype":"value","property":"P25","hash":"44b81cbbf6b2d038b4b7d86684a071cf08ad7770","datavalue":{"value":"3","type":"string"},"datatype":"string"},"type":"statement","id":"Q133803$3F171063-2158-4073-98C1-B921C54CE5D5","rank":"normal"}],"P128":[{"mainsnak":{"snaktype":"value","property":"P128","hash":"f0887bc2a5ab062c88d2dc4fb56acfe0918912ce","datavalue":{"value":"507-523","type":"string"},"datatype":"string"},"type":"statement","id":"Q133803$2A2CB2E5-73B7-44FA-BB57-14B51DA1F73A","rank":"normal"}],"P28":[{"mainsnak":{"snaktype":"value","property":"P28","hash":"251a8180674f25d7da0909ef6cdc4a843414945e","datavalue":{"value":{"time":"+2014-12-05T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q133803$0CCF0881-8416-4850-AE55-382736EEED98","rank":"normal"}],"P16":[{"mainsnak":{"snaktype":"value","property":"P16","hash":"5940fe3e07318c346554c3c9c7de48799e709763","datavalue":{"value":{"entity-type":"item","numeric-id":133801,"id":"Q133801"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q133803$6DFB16C9-3387-4284-88F2-635644912400","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P16","hash":"e161141ac78a48bedff5981580e3d25d4de56695","datavalue":{"value":{"entity-type":"item","numeric-id":133802,"id":"Q133802"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q133803$D8EAEF0C-513D-415C-B891-9B6F7B840823","rank":"normal"}],"P1460":[{"mainsnak":{"snaktype":"value","property":"P1460","hash":"57f7fea50d2ce1b39b695c4a1313582eed405e38","datavalue":{"value":{"entity-type":"item","numeric-id":5976449,"id":"Q5976449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q133803$2CD458A7-06BD-4982-BC79-62DA3A826A07","rank":"normal"}],"P27":[{"mainsnak":{"snaktype":"value","property":"P27","hash":"1f642d5050312d6d7fc8e91f96d34a9a366379d7","datavalue":{"value":"10.1111/RSSC.12089","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q133803$966F2BAC-8BB9-4A61-8F3E-14A6B13DCEB2","rank":"normal"}]},"sitelinks":{"mardi":{"site":"mardi","title":"Bayesian optimal interval designs for phase I clinical trials","badges":[],"url":"https://portal.mardi4nfdi.de/wiki/Bayesian_optimal_interval_designs_for_phase_I_clinical_trials"}}}}}